Hennion & Walsh Asset Management’s Globus Medical GMED Stock Holding History

Hennion & Walsh Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,493	Closed	-$372K	–	882
2024 Q4	$372K	Sell	4,493 -634	-12%	-$50K	0.02%	708
2024 Q3	$367K	Sell	5,127 -74	-1%	-$5.22K	0.02%	695
2024 Q2	$356K	Sell	5,201 -48	-0.9%	-$2.87K	0.02%	684
2024 Q1	$282K	Sell	5,249 -87	-2%	-$4.68K	0.02%	705
2023 Q4	$284K	Sell	5,336 -38	-0.7%	-$1.85K	0.02%	693
2023 Q3	$267K	Buy	5,374 +31	+0.6%	+$1.73K	0.02%	677
2023 Q2	$318K	Buy	+5,343	New	+$304K	0.02%	639

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hennion & Walsh Asset Management's GMED Position: Q1 2025 in Review

Hennion & Walsh Asset Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 4,493 shares — an estimated $372K sold.

Hennion & Walsh Asset Management first reported a position in GMED in Q2 2023 and held it in 7 quarters. The position peaked at $372K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Hennion & Walsh Asset Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Hennion & Walsh Asset Management sold 4,493 Globus Medical shares in Q1 2025, an estimated $372K.
Hennion & Walsh Asset Management first reported a position in Globus Medical in Q2 2023 and held it in 7 quarters.
Hennion & Walsh Asset Management's Globus Medical position peaked at $372K in Q4 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2025, filed 10 Apr 2025.